The use of remdesivir to treat severe cases of Coronavirus has been approved by the European Union.

This was announced by the European Union on Friday, July 3, days after the United States effectively stockpiled the world’s entire supply of the antiviral medication.

According to report, the approval of the drug ‘remdesivir’ came after two major US studies showed that remdesivir can reduce the duration of hospital stay for COVID-19 patients.

EU Health Commissioner Stella Kyriakides said in a statement;

“Today’s authorisation of a first medicine to treat COVID-19 is an important step forward in the fight against this virus.

“We are granting this authorisation less than a month after the  application was submitted, showing clearly the EU’s determination to respond quickly whenever new treatments become available.

Remdesivir which is the only anti-coronavirus medication to be given the green light in the EU was originally intended as a treatment for Ebola.

It was approved in UK at the end of May with health officials outlining that it would only be used to treat the sickest patients.

It is one of two drugs approved in Britain to treat COVID-19, the other being a cheap steroid called dexamethasone.